Almac launches COMPASS platform to improve clinical trial management
Almac has launched of its new forecasting platform, COMPASS, which has been designed to improve the accuracy and efficiency of the supply inventory process during clinical studies. COMPASS provides benefits to clients by allowing the Supply Chain Manager to proactively direct the entire clinical supply chain, ultimately saving money that is often lost through inaccurate forecasting or overproduction of supplies.
COMPASS allows the Supply Chain Manager to produce material forecasts for bulk product, finished goods, and packaging components. Typically a number of forecast scenarios are produced upfront using available data such as patient recruitment projections and protocol information. Clients can then select the most appropriate model to proceed with.
COMPASS can update the material forecast throughout the maintenance phase of the trial based on actual patient usage data. This allows the Supply Chain Manager to then review the system outputs and evaluate production and distribution strategies to ensure they are inline with the forecast.
COMPASS will be offered as part of Almac’s Supply Chain Management services at all sites and for customers of all sizes.